Clinical
FDA issues ambitious new draft guidance to promote clinical trial diversity | Hogan Lovells
FDA recommends the submission of a Plan for all medical products for which an IND submission is required or for which clinical studies are intended...
Now is the Time to Improve Diversity in Cancer Clinical Trial
Fewer African American and Hispanic patients participated in oncology trials from 2003 to 2016 than from 1996 to 2002.
Fewer African American and...
Clinical trials often lack diversity; revising eligibility rules may help, researchers say
Excluding people based on medical conditions unintentionally contributes to the underrepresentation of racial groups
Historically, participants of ...
Clinical Trial Eligibility Criteria: A Structural Barrier to Diversity in Clinical Trial Enrollment
Section:
ChooseTop of page <<REFERENCES
In the article that accompanies this editorial, Riner et al1 apply pancreatic cancer clinical tria...
Underrepresentation of Black Individuals in Clinical Trials for Lipid-Lowering Therapies
In randomized controlled trials (RCTs) for lipid lowering therapies since 1990, Non-Hispanic Black and African American (NHB/AA) patients are under...
Will Equality get Codified in Clinical Trials? Industry Continues to Miss Diversity Targets
Those who work in clinical trials know very well that securing patients for enrollment in studies is hard enough. However, finding minority and rac...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
